Literature DB >> 3866236

Dansylated estramustine, a fluorescent probe for studies of estramustine uptake and identification of intracellular targets.

M E Stearns, D P Jenkins, K D Tew.   

Abstract

Fluorescence-microscopic studies with dansylated estramustine (DnsEM) has permitted investigation of the mechanism of estramustine (EM) uptake in live human prostatic tumor cells (DU 145). DnsEM appeared to enter cells rapidly at the peripheral cell margins. A progressive increase in fluorescence was observed until the perinuclear material and cytoplasm were labeled brightly and the nucleoplasm was labeled faintly. Light microscopy showed that DnsEM is assimilated first in preexisting vesicles and then in numerous newly created vesicles that accumulate in the cytoplasm and around the nucleus. Colony-forming assays showed EM and DnsEM to be equally cytotoxic to cultured DU 145 cells. Cellular uptake and subsequent manifestation of cytotoxicity are presumably dependent upon these vesicles. However, after uptake of DnsEM, its diffusion into the cytoplasm was observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3866236      PMCID: PMC390940          DOI: 10.1073/pnas.82.24.8483

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Interaction of estramustine phosphate with microtubule-associated proteins.

Authors:  M Wallin; J Deinum; B Fridén
Journal:  FEBS Lett       Date:  1985-01-07       Impact factor: 4.124

Review 2.  The mechanism of action of estramustine.

Authors:  K D Tew
Journal:  Semin Oncol       Date:  1983-09       Impact factor: 4.929

3.  Cytotoxic properties of estramustine unrelated to alkylating and steroid constituents.

Authors:  K D Tew; B Hartley-Asp
Journal:  Urology       Date:  1984-06       Impact factor: 2.649

4.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

5.  Antimicrotubule effects of estramustine, an antiprostatic tumor drug.

Authors:  M E Stearns; K D Tew
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.

Authors:  P Björk; B Forsgren; J A Gustafsson; A Pousette; B Högberg
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

7.  Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).

Authors:  B Hartley-Asp; P O Gunnarsson
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

8.  Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.

Authors:  K D Tew; L C Erickson; G White; A L Wang; P S Schein; B Hartley-Asp
Journal:  Mol Pharmacol       Date:  1983-09       Impact factor: 4.436

9.  Chemotherapy of advanced, hormonally resistant prostatic carcinoma.

Authors:  S Madajewicz; R Catane; A Mittelman; Z Wajsman; G P Murphy
Journal:  Oncology       Date:  1980       Impact factor: 2.935

10.  High voltage electron microscopy studies of axoplasmic transport in neurons: a possible regulatory role for divalent cations.

Authors:  M E Stearns
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  6 in total

1.  Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.

Authors:  K D Tew; M E Stearns
Journal:  Urol Res       Date:  1987

Review 2.  The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking.

Authors:  J T Mack; V Beljanski; K D Tew; D M Townsend
Journal:  Biomed Pharmacother       Date:  2006-08-31       Impact factor: 6.529

3.  Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.

Authors:  J M Piepmeier; P E Pedersen; D Yoshida; C Greer
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

4.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

5.  Evaluation of lipophilins as determinants of tumor cell response to estramustine.

Authors:  Jody M Tucker; Zhanna Lipatova; Vladimir Beljanski; Danyelle M Townsend; Kenneth D Tew
Journal:  J Pharmacol Exp Ther       Date:  2005-08-24       Impact factor: 4.030

6.  Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.

Authors:  M E Stearns; M Wang; K D Tew; L I Binder
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.